Paper Details

  1. Home
  2. Paper Details

Preliminary studies of the pharmacokinetics and tolerability of zolmitriptan nasal spray in healthy volunteers.

Author: DixonRuth, NairnKevin, SeaberEmma, YatesRoger

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Two studies investigated the pharmacokinetics and tolerability of zolmitriptan nasal spray in healthy volunteers. Zolmitriptan was absorbed more rapidly after nasal spray administration than oral formulations, and all formulations were well tolerated.
Paper Details　
Original Abstract of the Article :
Two preliminary studies of the pharmacokinetics and tolerability of zolmitriptan nasal spray were conducted, each involving 12 healthy volunteers. In study 1, an initial double-blind, dose escalation phase (placebo or 2.5, 5.0, or 10 mg zolmitriptan intranasally) was followed by an open crossover ph...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/009127002762491325

データ提供：米国国立医学図書館（NLM）

Zolmitriptan Nasal Spray: A Camel's Tale of Migraine Treatment

The desert of migraine pain can be a relentless and debilitating experience, demanding effective treatment options. This study investigated the pharmacokinetics and tolerability of zolmitriptan nasal spray, a potential treatment for migraine headaches. The researchers conducted two preliminary studies to evaluate the drug's absorption, distribution, metabolism, and excretion in healthy volunteers. Their findings suggest that zolmitriptan nasal spray is rapidly absorbed and well-tolerated, offering a potential alternative for migraine treatment.

Zolmitriptan Nasal Spray: A Camel's Oasis for Migraine Relief

The study found that zolmitriptan nasal spray is rapidly absorbed, with detectable plasma concentrations as early as 5 minutes after dosing. The researchers observed similar pharmacokinetic profiles between the nasal spray and oral formulations, suggesting that the nasal spray could be a viable alternative for patients seeking rapid relief from migraine headaches.

Camel's Advice for Migraine Management

If you experience frequent migraines, it's essential to consult a doctor for proper diagnosis and treatment. Zolmitriptan nasal spray may be a suitable option for some individuals, but it's important to discuss the potential risks and benefits with your doctor. Remember, there are a variety of treatment options available to help you navigate the desert of migraine pain!

Dr.Camel's Conclusion

This research provides valuable insights into the pharmacokinetics and tolerability of zolmitriptan nasal spray for migraine treatment. The findings suggest that the nasal spray offers a potential advantage for rapid absorption and may be a viable alternative for patients seeking fast relief from migraine attacks. As we continue to explore the vast desert of migraine research, new and innovative therapies may emerge to provide even more effective and personalized treatment options for those who suffer from this debilitating headache disorder.

Date :
  1. Date Completed 2003-03-14
  2. Date Revised 2019-08-26
Further Info :

Pubmed ID

12412822

DOI: Digital Object Identifier

10.1177/009127002762491325

Related Literature

Article Analysis
・Effects of zolmitriptan nasal spray
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.